TY  - CHAP
M1  - Book, Section
TI  - Chapter 17B. Genomics and the Kidney
A1  - Joy, Melanie S.
A2  - Bertino, Joseph S.
A2  - DeVane, C. Lindsay
A2  - Fuhr, Uwe
A2  - Kashuba, Angela D.
A2  - Ma, Joseph D.
PY  - 2013
T2  - Pharmacogenomics: An Introduction and Clinical Perspective
AB  - To  inform  clinicians  about  the  role  of  genetic  variants  as  risk  factors  for  kidney  diseases.To  assist  clinicians  in  understanding  how  genomics  can  influence  kidney  disease  progression.To  inform  clinicians  about  the  contribution  of  pharmacogenomics  toward  patient  care  for  kidney  disorders.To  provide  clinicians  with  an  understanding  of  how  polymorphisms  in  drug  metabolism  and  disposition  genes  can  influence  risks  for  drug-induced  nephrotoxicity.  
SN  - 
PB  - The McGraw-Hill Companies
CY  - New York, NY
Y2  - 2024/04/18
UR  - accesspharmacy.mhmedical.com/content.aspx?aid=56878366
ER  -